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In this paper, we describe studies to identify additional
residues in the highly conserved stretch surrounding Glu-404
that are involved in potassium coupling. Only one, the neighboring residue, Tyr-403, exhibits this phenotype. However,
unlike E404D, transporters in which the tyrosine is replaced by
other aromatic amino acid residues (Y403F and Y403W)
exhibit a marked increase in sodium affinity and a striking
broadening of cation selectivity. These and other observations
suggest that sodium- and potassium-binding sites of GLT-1
overlap.

ABSTRACT
Glutamate transporters remove this neurotransmitter from the synaptic cleft by a two-stage electrogenic
process, in which glutamate is first cotransported with three
sodium ions and a proton. Subsequently, the cycle is completed by translocation of a potassium ion in the opposite
direction. Recently, we have identified an amino acid residue
of the glutamate transporter GLT-1 (Glu-404) that inf luences
potassium coupling. We have now analyzed the effect of seven
other amino acid residues in the highly conserved region
surrounding this site. One of these residues, Tyr-403, also
proved important for potassium coupling, because mutation
to Phe (Y403F) resulted in an electroneutral obligate exchange
mode of glutamate transport. This mutation in the transporter also caused an approximately 8-fold increase in the
apparent sodium affinity, with no change in the apparent
affinity for L-glutamate or D-aspartate. Strikingly, although
exchange catalyzed by the wild-type transporter is strictly
dependent on sodium, the selectivity of Y403F mutant transporters is altered so that sodium can be replaced by other
alkaline metal cations including lithium and cesium. These
results indicate the presence of interacting sites in or near the
transporter pore that control selectivity for sodium and
potassium.

EXPERIMENTAL PROCEDURES
Cell Growth and Expression. HeLa cells were cultured (19),
infected with recombinant vacciniayT7 virus vTF7–3 (20), and
transfected with plasmid DNA encoding wild-type or mutant
GLT-1, as described (19). Solubilization of transporters expressed in the HeLa cells, their reconstitution in proteoliposomes (11, 15), and transport measurements (11, 15) were done
as described. Data presented are after subtracting the values
obtained from cells transfected with the vector Bluescript SK2
alone. Exchange data are presented as net exchange after
subtracting the values obtained on proteoliposomes not containing 10 mM L-aspartate but only 0.12 M Tris phosphate (pH
7.4). These values are negligible (see ref. 11). Protein was
determined by Lowry’s method (21).
Electrophysiology. Capped mRNAs encoding wild-type or
mutant transporters were injected into state V–VI Xenopus
oocytes (50 ng per oocyte) and currents were recorded by using
a two-microelectrode voltage-clamp circuit (11). Recording
solution (Ringer’s solution) contained 100 mM NaCl, 2 mM
KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM Hepes (pH 7.4).
For recordings in the presence of NO2
3 , NaCl was partially
substituted by NaNO3 (20 mM).
Site-Directed Mutagenesis. Mutagenesis (22, 23) was done
by using uracil-containing single-strand DNA derived from the
shortened GLT-1 clone (24). After verification of the mutants
by DNA sequencing, the mutations were subcloned into wild
type by using either HindIIIyAsp700yBstEII (22) or BsrGIy
BstEII. Subcloned DNAs were sequenced in both directions
between the BstEII site and the Asp700 or BsrGI site.

Glutamate transporters limit receptor activity by maintaining
low synaptic concentrations of the transmitter (1–3) and by
buffering synaptically released transmitters (4). Transport
occurs by an electrogenic process (5–7) where the transmitter
is cotransported with three sodium ions and a proton (8),
followed by countertransport of a potassium ion (9–11). It has
been postulated that potassium binds at a site previously
occupied by one of the sodium ions (12). Despite the detailed
mechanistic knowledge, little is known about the structural
determinants of the translocation pathway.
A glutamate transporter has been purified to near homogeneity and reconstituted (13, 14). It represents around 0.6%
of the protein of crude synaptosomal fractions and is one (15)
of four glutamate transporters expressed in brain that have
been cloned thus far (16–18). Recently, we identified a residue
of the cloned glutamate transporter GLT-1 (15) important for
potassium coupling (Glu-404) (11). This residue is located in
the most conserved region of the glutamate transporter family.
It is essential for potassium coupling (11), and the defect is
very specific. Thus, transporters where this residue is mutated
to Asp (E404D) exhibit a sodium affinity that is identical to
that of the wild type (11). The E404D transporters are locked
in an obligatory exchange mode. Apparently, they are not able
to functionally interact with potassium, which normally interacts with the wild-type transporter after the sodium and acidic
amino acid (AAA) have been transported and released (9–11).

RESULTS
The defect in potassium coupling in E404D-GLT-1 appears to
be caused by defective potassium binding from either side of
the membrane (11). This implies that other residues of GLT-1,
close to E404D in space, also should be involved in binding the
potassium. To identify such residues, we have mutated residues
of GLT-1 located near Glu-404 in the primary sequence of the
transporter. Fig. 1A shows the sodium-dependent uptake of
the nonmetabolizable substrate D-[3H]aspartate in HeLa cells,
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FIG. 1. (A) Sodium-dependent D-[3H]aspartate uptake in HeLa
cells expressing wild-type and mutant transporters. Values are the
average 6 SEM of triplicate determinations. (B) Sodium-dependent
uptake of D-[3H]aspartate in proteoliposomes prepared from HeLa
cells expressing wild-type (}) and mutant transporters. The following
mutant GLT-1 transporters were tested: T400S, F; A401C, E; L402M,
Œ; Y403F or E404D, ‚ (the same symbol is used for both because the
values are superimposable); A405C, ƒ; V406C, ■; A407C, h. The
medium contained 0.12 M potassium phosphate (pH 7.4). The protein
concentration was in all cases around 1 mgyml; data are expressed as
pmolymg of protein to normalize for the small variations in protein
content resulting from individual reconstitutions. Reactions were
stopped at the indicated times.

expressing mutant transporters with replacements in the highly
conserved residues 400–407. With the exception of T400S, the
mutants exhibit uptake levels of at least 50% of that of the wild
type (Fig. 1 A). The Thr at position 400 is important for
expression of glutamate transport, because only residual activity is observed when it is replaced by Ser (Fig. 1 A) and none
whatsoever is observed when it is replaced with Ala, Cys, or
Asn (data not shown).
E404D-GLT-1 transporters are locked in an obligatory
exchange mode (11). To determine whether the uptake in the
intact cells of the mutants at positions 400–407 represents
exchange with the endogenous AAA or trans-potassiumdependent net flux, the transporters from these cells were
solubilized and reconstituted. Similar to the wild type (11), in
the majority of the mutant transporters sodium-dependent net
flux of the radiolabeled aspartate is observed after their
reconstitution into potassium-loaded proteoliposomes (Fig.
1B). Only the transporters mutated at position 403, Y403FGLT-1, are defective in this activity (Fig. 1B) just as E404D-
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GLT-1 (Fig. 1B, ref. 11). The same is true for net flux of
L-[3H]glutamate (data not shown). It should be noted that with
most other mutants, including T400S, the activity is more or
less proportional to what is observed in the intact cells (Fig. 1
A and B). Thus the defect in T400S-GLT-1 is not caused by a
defective interaction with potassium. The net flux by A407CGLT-1 in the reconstituted system is low relative to the uptake
in the whole cells, but this case is less extreme than Y403FGLT-1, which is totally defective in net flux (Fig. 1 A and B).
In reconstituted proteoliposomes, no sodium-dependent
uptake is observed with the wild type when trans-potassium is
replaced by other cations such as Tris (11) and also is not
observed in Y403F-GLT-1 (data not shown). However, if
potassium-free proteoliposomes inlaid with the wild type
contain in addition internal L-aspartate (or other transportable
AAA) exchange takes place and substantial D-[3H]aspartate is
accumulated in a sodium-dependent fashion (11). The Y403FGLT-1 transporters similarly catalyze this exchange (Fig. 2,
zero time and also see Fig. 5). These results indicate that, just
like E404D-GLT-1, Y403F-GLT-1 is also locked in the exchange mode and is unable to catalyze net uptake. Thus it does
not interact with internal potassium (Fig. 1B). It also cannot
interact with external potassium. The latter promotes a net
efflux of internal D-[3H]aspartate from the wild type but not
in the mutant (Fig. 2). In these experiments D-[3H]aspartate
was accumulated before the efflux by exchange into proteoliposomes containing sodium ions and unlabeled L-aspartate.
Net efflux from mutant liposomes was also not observed by
using other cations in the external solution, namely, rubidium,
cesium, and lithium (data not shown). The only way to deplete
the Y403F-GLT-1 liposomes from the D-[3H]aspartate (previously accumulated by exchange) is by back exchange herein
demonstrated with external glutamate (Fig. 2).
Fig. 3 provides electrophysiological evidence that Y403F
transporters are locked in the exchange mode. In standard
sodium and chloride containing medium, glutamate induces a
slow capacitative current and a relatively small steady-state
current in voltage-clamped oocytes expressing Y403F transporters (Fig. 3A). These currents are reminiscent of those
observed in E404D (11), and neither is observed in waterinjected oocytes (7). The small steady-state inward current of
Y403F becomes outward at potentials more positive than 230

FIG. 2. Efflux of D-[3H]aspartate from wild type (Left) or Y403F
proteoliposomes (Right) in which it was previously accumulated by
exchange. For each time, 20 ml of proteoliposomes containing 0.12 M
sodium phosphate and 10 mM L-aspartate was loaded with D-[3H]aspartate by dilution into 80 ml of 0.15 M NaCl and 1 mCi of labeled
aspartate (1 Ci 5 37 GBq). After 10 min, the mixture was diluted into
1 ml of 0.15 M NaCl (■), 20 mM KCly130 mM NaCl (Œ), 150 mM KCl
(F), or 0.15 M NaCly100 M L-glutamate (). Reactions were terminated at the times indicated at the abscissa.
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FIG. 3. (A) Difference records obtained by subtraction of currents
recorded in the absence of glutamate from records in the presence of
100 mM L-glutamate in oocytes expressing the mutant Y403F transporter. Pulses are 100 ms in duration in 20-mV increments to potentials
between 2120 mV and 140 mV from a holding potential of 230 mV.
Dashed line shows zero current. (B) Same protocol and oocyte as in
A showing shift in the reversal potential from 230 mV (ECl) to
approximately 260 mV after substitution of 20 mM Cl with NO3. (C)
Summary of voltage dependence of glutamate-induced currents (mean
6 SEM, n 5 4) recorded in 100 mM NaCl (squares) or 80 mM NaCly20
mM NaNO3.

mV—the electrochemical equilibrium potential of chloride. In
contrast, wild-type GLT-1 exhibits much larger steady-state
currents that do not reverse up to 140 mV (11). Uptake of
excitatory amino acids by all glutamate transporter clones
characterized thus far—including wild-type GLT-1—results in
activation of a current reflecting the sum of the transport
current, which is inward at all potentials (resulting from net
sodium-coupled glutamate influx), with a chloride current
flowing through a thermodynamically uncoupled pathway (11,
18, 25). At the equilibrium potential of chloride, wild-type
GLT-1 still exhibits the transport current (11), but Y403F
transporters do not exhibit it (Fig. 3 A and C). This is to be
predicted if Y403F transporters can only carry out exchange
but not net flux. That the currents observed with Y403F are
caused by anion flux is further illustrated by the fact that
substitution of part of the external chloride by the much more
permeant nitrate (20 mM) results in a shift of the reversal
potential to approximately 260 mV and much larger outward
currents are observed (Fig. 3 B and C). This is to be predicted
by the well-characterized selectivity sequence of the anion
conductance activated during uptake mediated by cloned
transporters favoring chaotropic anions (25, 26).
In striking contrast with E404D (11), Y403F-GLT-1 exhibits
a highly increased sodium affinity—8-fold in the experiment
shown (Fig. 4). Similar results also are obtained in voltageclamped oocytes (data not shown). The K0.5 for sodium—the
concentration giving rise to a 50% activation of transport—is
23.8 6 3.0 mM (mean 6 SEM, n 5 4) for the wild type and
3.7 6 0.7 mM (n 5 3) for Y403F. The dose–response curve for
the mutant is characterized by an apparent inhibitory phase
after the maximum activation. It is possible that this also could
occur in the wild type, but because of its lower affinity, it would
require hyperosmotic conditions to become apparent. If we
determine K0.5 for sodium relative to the value at 150 mM, an
even lower value is obtained for Y403F—2.7 6 0.6 mM (n 5
3). The cooperativity with regard to sodium is essentially
unchanged in the mutant; the Hill coefficients for wild type
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FIG. 4. Sodium dependence of D-[3H]aspartate uptake in HeLa
cells expressing wild-type (■) or Y403F-GLT-1 (F) transporters.
Transport was measured by using influx solutions containing the
indicated NaCl concentrations that were supplemented with choline
chloride to a final concentration of 150 mM. Values are the averages 6
SEM of triplicate determinations.

and Y403F-GLT-1 are 1.80 6 0.04 (n 5 4) and 1.91 6 0.05 (n 5
3), respectively. This increased sodium affinity is not only
observed in intact HeLa cells expressing the mutant transporters but also in reconstituted proteoliposomes inlaid with
them (data not shown).
The impaired potassium binding and increased sodium
affinity suggested to us that perhaps the binding sites for
sodium and potassium interact closely. This raises the possibility that mutations at Tyr-403 may influence ion selectivity
at the sodium binding site. We have tested this idea by
monitoring the ion specificity of exchange by Y403F transporters under conditions where this process is completely
dependent on external sodium in the wild type. With wild-type
glutamate transporters, exchange will proceed only when
sodium is present on at least one side of the membrane (9, 10).
In the experiment depicted in Fig. 5, exchange of D-[3H]aspartate is measured into liposomes inlaid with either wild type
or Y403F-GLT-1 that are loaded with internal Tris and Laspartate. Indeed, under these conditions the exchange of
D-[3H]aspartate into liposomes inlaid with wild-type GLT-1 is
completely dependent on external sodium (Figs. 5 Left).
Strikingly, lithium but not choline supports significant exchange in sodium-free Y403F-GLT-1 liposomes (Fig. 5A
Right). Its extent amounts to 33.8 6 3.5% (n 5 4) of that in
sodium. Thus, unlike in the wild type, in the mutant, sodium
ions can be replaced by lithium to form the translocation
complex (9–11). The lack of exchange in choline indicates that
not only this cation but also protons cannot replace the sodium
or lithium in the mutant. Consistent with this is the failure to
observe exchange at pH 5.8 (by using Bis-Tris medium, data
not shown). Of the other cations also tested, cesium is able to
replace sodium in the Y403F mutant transporters but not in
the wild type (Fig. 5B Right). The extent is 60.1 6 6.4% of that
in sodium (n 5 3). On the other hand ammonium and
potassium are not able to do so (Fig. 5B).
Although we have noted three functional changes in the
Y403F mutant—inability to interact with potassium, increased
sodium affinity, and a broadening of the specificity for the
sodium site—it is important to note that the overall conformation of the transporter has not changed because of the
mutation. Not only does the glutamate-induced anion conductance appear unaltered (Fig. 3) but also the apparent Km and
Vmax for D-aspartate and L-glutamate are not significantly
changed. The apparent Km values for D-aspartate exchange for
wild type and Y403F transporters are 5.1 6 0.4 and 5.6 6 0.9
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FIG. 5. (A) Exchange of D-[3H]aspartate in proteoliposomes prepared from HeLa cells expressing wild-type (WT) (Left) or Y403F
(Right) transporters. The medium contained 120 mM Tris phosphate
(pH 7.4) with and without 10 mM L-aspartate. Trans-L-aspartatedependent exchange is shown in external medium containing 150 mM
NaCl, 150 mM LiCl, or 150 mM choline chloride as indicated. (B) Ion
specificity of exchange of D-[3H]aspartate in wild-type or Y403F
transporters. Conditions are as in A, where the chloride salts of the
indicated cations at 150 mM are added to the external medium.

mM (mean 6 SEM, n 5 4), respectively. For L-glutamate, the
corresponding values are 6.4 6 1.4 and 7.3 6 1.2 mM (n 5 3).
To better understand the role of Tyr-403 in the interaction
of the transporter with potassium and sodium, we have mutated it to a nonaromatic (Cys, Y403C) or to the other aromatic
(Trp, Y403W) residue. Neither of these mutant transporters is
able to carry out net flux of D-[3H]aspartate into reconstituted—potassium-loaded—proteoliposomes (Fig. 6A). Nevertheless, intact HeLa cells expressing these mutants are able to take
up this AAA (Fig. 6B), strongly suggesting that this is caused
by exchange with endogenous AAA. This is in fact what
happens as shown by using aspartate-loaded proteoliposomes
inlaid with the mutant transporters (Fig. 6C). Interestingly, the
Y403W transporter shows both increased sodium affinity (Fig.
6B)—K0.5 for sodium 3.8 6 0.2 mM (n 5 3) and broadened ion
selectivity (Fig. 6C Left) just like Y403F (Figs. 4 and 5). The
extents in lithium and cesium are 38.6 6 8.2% (n 5 3) and
59.5 6 9.5% (n 5 3) of that in sodium. On the other hand
Y403C transporters neither exhibit the increased sodium affinity—K0.5 for sodium 28.3 6 6.0 mM (n 5 3)—nor the
broadened ion selectivity. Neither of the mutants showed a
marked change in the Hill coefficient for sodium, 1.88 6 0.05
(n 5 3) and 1.72 6 0.05 (n 5 3) for Y403W and Y403C,
respectively. These observations strongly suggest that the
changes in sodium affinity and selectivity are closely linked.

FIG. 6. (A) Net sodium-dependent D-[3H]aspartate influx into
potassium-loaded proteoliposomes of wild-type, Y403W, and Y403C
transporters. The proteoliposomes were loaded with 0.12 M potassium
phosphate, and transport values after 10 min (mean 6 SEM, n 5 3
determinations) are given. (B) Sodium dependence of D-[3H]aspartate
uptake in HeLa cells expressing wild-type (■), Y403C (Œ), and Y403W
(F) transporters. Conditions were as in Fig. 4. (C) Ion specificity of
D-[3H]aspartate exchange in Y403W and Y403C transporters. Experimental conditions as in Fig. 5.

DISCUSSION
The fact that all of the mutants at position 403 lose their ability
to interact with potassium—regardless of the nature of the side
chain inserted—strongly suggests that Tyr-403 is part of the
potassium binding site, just like Glu-404 (11). In contrast to the
effect on potassium, the nature of the side chain of the
substituted amino acid residue at position 403 determines
whether both sodium affinity and selectivity are affected. This
and the fact that E404D-GLT-1 and the wild type have the
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identical sodium affinity (11) indicate that sodium and potassium binding sites are not identical, in contrast to a previous
suggestion (12). Our results, however, indicate that the sodium-selective site is located sufficiently close to the potassium
site so that it can sense the change at Tyr-403, at least when
bulky aromatic residues replace it.
During a single turnover of the glutamate transporter, three
sodium ions are translocated (8). Single mutations at position
403 alter the sodium selectivity (Figs. 5 and 6C). Does this
mean that all three sodium ions interact with the same binding
site? This is not necessarily so, as our previous observations
suggest the presence of nonidentical multiple sites, some of
which may bind lithium (27). It is possible that in the wild type
only one out of the three sites is strictly sodium-selective and
cannot bind lithium. The aromatic substitutions of Tyr-403
could render this specific sodium site less specific.
It is of interest to note that the analogous tyrosine (Tyr-405)
from the related transporter GLAST-1 (16) has been implicated in the binding of the d-carboxyl group of glutamate (28).
This interpretation is hard to reconcile with the lack of effect
on AAA affinity in the Y403F mutant that we have observed.
The lack of currents observed with Y405F-GLAST-1 (28) is in
harmony with our conclusion that the transporter is locked in
the exchange mode. The very low radioactive uptake observed
in this mutant (28) could be caused by a low expression in the
oocytes relative to the expression system used herein. Nevertheless, we have introduced the Y405F mutation in GLAST-1
(provided by W. Stoffel, University of Cologne, Germany) and
the behavior of Y405F-GLAST-1 was undistinguishable from
that of Y403F-GLT-1 (data not shown).
The close relation of potassium and sodium binding tempts
us to speculate on the location of the sodium binding site. This
could be close to positions 403 and 404 in the primary
structure, but alternatively, it could be located in a completely
different stretch of amino acid residues that could be close to
the potassium-binding residues in space. The latter is difficult
to assess at present as high-resolution structural information is
lacking. Several lines of circumstantial evidence indicate that
the first possibility may be correct and that part of it may be
formed by residues occupying positions 396–400. (i) No sodium binding transient currents were observed with transporters mutated at the absolutely essential Asp-398 (22) and the
inactive mutant N396Q in which Asn-396 was replaced by Gln
(data not shown). (ii) Cys scanning mutagenesis indicates that
each of the five residues 396–400 when replaced by Cys gives
rise to inactive transporters (R.Z., M. Grunewald, M.P.K., and
B.I.K., unpublished observations). (iii) The T400S and A401G
mutants exhibit a greatly impaired sodium affinity (data not
shown).
With respect to the potassium site itself, it would appear that
there should be other residues that may ligand potassium in
addition to Tyr-403 and Asp-404. One residue that at least
influences interaction of the transporter with potassium is
Ala-407 (Fig. 1). Although the secondary structure of this
region is not known, it is of interest to note that if it were
a-helical, position 407 would be precisely one turn away from
positions 403 and 404 and thus very close to them. In view of
the close relationship between sodium and potassium sites
suggested by our study, it is possible that some of the residues
between positions 396 and 400 may be involved in both sodium
and potassium binding. This would not be revealed with the
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assays currently at our disposal. Alternatively, additional residues forming the potassium site may be located in other parts
of the primary structure and may be revealed by subjecting
other highly conserved regions to the type of analysis outlined
herein.
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